PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR

Sponsor
Washington University School of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT05349084
Collaborator
(none)
35
1
1
45.8
0.8

Study Details

Study Description

Brief Summary

The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information.

Patients already scheduled to undergo Invasive coronary catheterization (ICA) for the clinical indication of angina will be recruited to under go stress-rest Positron Emission Tomography-Coronary CT Angiography-Fractional Flow Reserve (PET-cCTA-cFFR)

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: PET-cCTA-cFFR
N/A

Detailed Description

This is a single cohort, technology assessment study. Thirty-five patients presenting with stable angina and a moderate pretest likelihood for CAD who are already scheduled to undergo invasive coronary angiography (ICA) for the clinical indication of angina will be recruited to undergo a cCTA examination with FFR followed immediately by regadenoson stress-rest PET on the same PET/CT scanner.

We will derive sensitivity, specificity, NPV, PPV of CTA-cFFR compared to the reference standard of standard of care ICA with FFR for each epicardial coronary artery.

We will correlate segmental stress PET MBF to presence or absence of a coronary artery stenosis ≥ 50% diameter on CCTA and ICA.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
Actual Study Start Date :
Jun 6, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: PET-cCTA-cFFR

patients presenting with stable angina and a moderate pretest likelihood for CAD who are already scheduled to undergo ICA for the clinical indication of angina will be recruited to undergo PET-cCTA-cFFR

Diagnostic Test: PET-cCTA-cFFR
patients presenting with stable angina and a moderate pretest likelihood for CAD who are already scheduled to undergo ICA for the clinical indication of angina will be recruited to undergo PET-cCTA-cFFR

Outcome Measures

Primary Outcome Measures

  1. CT presence of flow-limiting coronary artery stenosis [Day 1 - Day of Scan]

    CT presence of flow limiting stenosis (≤ 0.8) as determined by CT-FFR in comparison to invasive coronary artery (ICA) FFR.

  2. PET presence of decreased myocardial myocardial blood flow (MBF) [Day 1 - Day of Scan]

    Decreased MBF (mL/g/min) in regions of coronary stenosis ≥ 50% diameter by CCTA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-90 years of age, of either sex

  • Patients presenting with stable angina and a moderate pretest likelihood for CAD and scheduled to undergo ICA for the clinical indication of angina. Subjects will undergo this study within 45 days prior to the cardiac catheterization. This study can also be performed 45 days after the cardiac catheterization if the patient had no interventions.

Exclusion Criteria:
  • Prior history of stenting, coronary artery bypass graft surgery, or myocardial infarction, unstable angina, atrial fibrillation, second or third degree atrioventricular block, class IV heart failure

  • Iodine allergy

  • Renal dysfunction (creatinine above normal laboratory limits)

  • Symptomatic asthma

  • Women who are pregnant or breast-feeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT05349084
Other Study ID Numbers:
  • 201904112
First Posted:
Apr 27, 2022
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022